Article info

Download PDFPDF

Deciphering the vedolizumab dosing conundrum in IBD: when less is more

Authors

  1. Correspondence to Dr Britta Siegmund, Medical Department I, Charite Universitatsmedizin Berlin Campus Benjamin Franklin, 12200 Berlin, Germany; britta.siegmund{at}charite.de
View Full Text

Citation

Adolph TE, Siegmund B
Deciphering the vedolizumab dosing conundrum in IBD: when less is more

Publication history

  • Received August 22, 2021
  • Accepted August 31, 2021
  • First published September 8, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.